Correlation Between ZyVersa Therapeutics and Enzolytics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Enzolytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Enzolytics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Enzolytics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Enzolytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Enzolytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Enzolytics.
Diversification Opportunities for ZyVersa Therapeutics and Enzolytics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between ZyVersa and Enzolytics is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Enzolytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzolytics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Enzolytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzolytics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Enzolytics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Enzolytics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Enzolytics. In addition to that, ZyVersa Therapeutics is 1.05 times more volatile than Enzolytics. It trades about -0.1 of its total potential returns per unit of risk. Enzolytics is currently generating about -0.08 per unit of volatility. If you would invest 4.38 in Enzolytics on August 31, 2024 and sell it today you would lose (4.29) from holding Enzolytics or give up 97.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 99.73% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Enzolytics
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Enzolytics |
ZyVersa Therapeutics and Enzolytics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Enzolytics
The main advantage of trading using opposite ZyVersa Therapeutics and Enzolytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Enzolytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will offset losses from the drop in Enzolytics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Enzolytics vs. Creative Medical Technology | Enzolytics vs. Regen BioPharma | Enzolytics vs. Therasense | Enzolytics vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |